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Background: The A20 ubiquitin-editing enzyme is a target of nuclear factor kappa B (NF-κB) and also plays a key
role in regulating the NF-κB signaling pathway. NF-κB activity is increased during human cytomegalovirus (HCMV)
infection and HCMV appears to be adapted to this change. To better understand the regulation of NF-κB signaling
during HCMV infection, we investigated how A20 expression is controlled during HCMV infection.
Methods: The expression level of A20 in human fibroblast cells infected with HCMV or UV-inactivated virus (UV-HCMV)
was measured by immunoblot analysis, cell staining, and quantitative real-time PCR. Changes of histone modifications
on the A20 promoter were determined by chromatin immunoprecipitation assays. Lentiviral vectors were used to
knockdown A20 in fibroblast cells.
Results: A20 expression was increased at early times after HCMV infection. This increase of the A20 protein level was
promoted by viral gene expression under low viral load conditions. The viral IE1 protein, which is known to activate
NF-κB, increased the A20 promoter activity through the upstream NF-κB sites in reporter assays, suggesting that IE1 is
at least partly involved in A20 induction. Analysis of A20 expression with a high viral load demonstrated that the A20
regulation by HCMV was biphasic; both A20 protein and mRNA levels were increased at the early stage of infection,
but decreased at the late stage. Under high viral load conditions, A20 upregulation was more profound with UV-HCMV
than with HCMV, indicating a role of the viral gene product(s) in limiting A20 induction. Consistently, more histone
modifications for euchromatin were found on the A20 promoter during UV-HCMV infection than with HCMV infection.
A20 knockdown by shRNA reduced HCMV growth.
Conclusion: These results suggest that the biphasic regulation of A20 expression may be important for productive
HCMV infection.
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The nuclear factor-kappa B (NF-κB) signaling pathway
controls inflammation, the immune response, and cell
survival during viral infections. The regulation of NF-κB
signaling during human cytomegalovirus (HCMV) infection
is complicated. The pro-viral role of NF-κB for HCMV
gene expression is suggested by the presence of the NF-κB
sites on the viral major immediate-early (IE) promoter, and
the IE1 protein autoregulates its own promoter through
upstream NF-κB sequences [1]. HCMV appears to activate
NF-κB at different levels. For example, NF-κB is highly* Correspondence: jahn@skku.edu
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unless otherwise stated.induced in HCMV-infected fibroblasts [2]. Binding of
viral glycoproteins to cell receptors activates NF-κB in
fibroblasts and monocytes [3,4]. In addition, NF-κB
upregulation is mediated by viral IE proteins through
induction of the cellular factor, Sp1, which activates
the NF-κB p105/p50 and p65 subunit promoters [3,5].
The role of IE1 in the induction of NF-κB is demonstrated
in vascular smooth muscle cells, where IE1 selectively
induces nuclear RelB and p50 among NF-κB/Rel factor
[6], particularly through Jun kinase and c-Jun/Fra-2
AP-1 complexes for RelB induction [7].
Since NF-κB activity leads to an increase in antiviral
inflammatory cytokine expression, an antiviral role for
NF-κB signaling during viral infection is expected. When
NF-κB activation is blocked, cytokines that inhibit HCMVThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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overexpression of IκB kinase β (IKKβ) inhibits HCMV
replication [8]. Thus, viruses appear to establish several
strategies to interfere with innate immunity by preventing
NF-κB pathway activation [9]. IE2 inhibits tumor necrosis
factor α-induced NF-κB DNA binding, leading to suppres-
sion of the IFN-β promoter [10].
A20, a ubiquitin-editing enzyme that belongs to the
OTU domain family of deubiquitinases (DUBs), is induced
by NF-κB and also acts as a negative regulator of NF-κB
signaling, playing a critical role in terminating NF-κB
responses to various stimuli [11]. A20 DUB activity
cleaves K63-linked poly-ubiquitin chains from RIP1
[12] and TRAF6 [13]. In addition, A20 harbors atypical
zinc finger-dependent K48-specific E3 ubiquitin ligase
activity that adds K48-linked poly-ubiquitin chains to
RIP1, inducing its degradation [12]. A20 also promotes
proteasomal degradation of ubiquitin E2 conjugating
enzymes, Ubc13 and UbcH5, involved in NF-κB signaling
[14]. By targeting IκB kinase γ (IKKγ), A20 also non-
catalytically inhibits TNFR-mediated signaling [15].
The importance of A20 in NF-κB regulation is shown
in in vivo studies demonstrating that A20-deficiency
in mice results in excess NF-κB activity and increased
inflammation in several organs [13,16]. Furthermore,
A20 is reported to stabilize NF-κB-inducing kinase
(NIK), promoting the transition from canonical to non-
canonical NF-κB activation for proper immune system
control [17].
It has been shown that A20 is induced in human
monocytes after HCMV infection and that the binding
of viral glycoproteins to cellular receptors plays a role in
this induction [4]. In the present study, we investigated
how A20 expression is regulated in human fibroblasts
after HCMV infection. We showed that A20 expression
is biphasically regulated during HCMV infection. A20
expression was initially increased at early times of infection
but inhibited at later stages. We also found that the viral
IE1 protein activates the A20 promoter through the
upstream NF-κB biding sites, suggesting a role of IE1 in
the initial A20 activation. Analysis of A20 expression
with a high viral load demonstrated that the newly
synthesized viral gene product(s) epigenetically limit the
upregulation of A20 transcription. We also found that
A20 knockdown reduces HCMV growth, suggesting
that the biphasic regulation of A20 expression may be
important for productive HCMV infection.Results
Effect of HCMV infection on A20 expression
We investigated how the A20 protein level is regulated
during HCMV infection. HF cells were infected with
HCMV or UV-inactivated virus (UV-HCMV) at differentmultiplicities of infection (MOI) (from 0.2 to 10) and the
A20 protein level at 24 h after infection was measured by
immunoblotting. The A20 level was increased by HCMV
infection at an MOI of 0.2, 0.5, 1, and 3, showing peak
induction at an MOI of 3, but this increase was reduced
at an MOI of 10. UV-HCMV infection less effectively
upregulated the A20 level than HCMV at relatively low
MOIs (from 0.2 to 3); however, it more effectively up-
regulated A20 than HCMV at an MOI of 10 (Figure 1A).
We also examined the time-course effect of HCMV
infection on the A20 level at an MOI of 0.5. The results
showed that the A20 level was increased from the early
phases of infection. UV-HCMV less effectively upregulated
the A20 level than HCMV during the early phases, whereas
it more effectively upregulated the A20 level than HCMV
at 72 h (Figure 1B). Considering that the MOI-dependent
difference often reflects the progression of infection, these
results suggest that A20 expression is induced at the
early phases of infection, but this induction may be
downregulated at the late phases. Our analysis with
UV-HCMV also suggests that the newly expressed viral
gene product(s) may promote A20 expression at early
times under low MOI conditions.
The A20 levels determined by immunobot analysis
reflect the mean values of A20 proteins of the whole
cell population. To examine the induction of A20 by
HCMV infection at the single cell level, we infected HF
cells with HCMV at an MOI of 0.5 for 24 h and stained
the cells for A20 and IE1. The results of IFA showed
that the A20 signals were increased in virus-infected
(IE1-positive) cells in both the nucleus and cytoplasm
to a higher level than in cells treated withTNFα (Figure 1C
and D). Together, these results support the idea that
HCMV infection results in a modest increase in A20
protein level during the early stage of virus infection.Evaluation of the IE1-mediated NF-κB activation on A20
promoter activity
Since HCMV IE1 induces NF-κB activity, it is expected
that the A20 promoter, which contains the NF-κB binding
sequences, is also activated by IE1. To test this, transient
transfection reporter gene assays were performed in
HCMV-permissive HF cells using the luciferase reporter
plasmid pA20(NF-κB)-Luc, which contains the A20
promoter region (from −95 to +9) with two NF-κB sites,
and a synthetic pNFκB-Luc plasmid, which contains four
copies of NF-κB sites (Figure 2A). We found that IE1
substantially increased the activity of both the A20 pro-
moter and the synthetic promoter (Figure 2B). HCMV
IE2 did not significantly affect either promoter, and
when both IE1 and IE2 were expressed together, IE2
did not affect IE1-mediated A20 promoter activation,
although it interfered with the IE1 activity for the NF-κB
Figure 1 Effect of HCMV infection on A20 protein level. (A) HF cells were infected with HCMV or UV-inactivated virus (UV-HCMV) at the indicated
MOIs. Total cell lysates were prepared at 24 h and immunoblotted with anti-A20 and anti-β-actin Abs. (B) HF cells were infected with HCMV or UV-HCMV
at an MOI of 0.5 for the indicated times, followed by immunoblotting as in (A). (C) HF cells were untreated or treated with TNF-α (50 ng/ml) for 2 h. Cells
were fixed with the paraformaldehyde procedure and IFA was performed with anti-A20 Ab. A mounting solution containing Hoechst dye was used to
stain cell nuclei. FITC-conjugated anti-mouse IgG and rhodamine/Red X-coupled anti-rabbit IgG Abs were used for visualization. (D) HF cells were
mock-infected or infected with HCMV at an MOI of 0.5 for 24 h. Cells were fixed and stained with anti-A20 and anti-IE1 Abs as in (C). For
visualization, rhodamine/Red X-coupled anti-mouse IgG and FITC-conjugated anti-rabbit IgG Abs were used.
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set of A20 reporter plasmids; pA20(Wt)-Luc, which
contains six Sp1 sites and NF-κB sites, and its NF-κB
site mutant version, pA20 (mNF-κBs)-Luc (Figure 2A).
The results of similar transfection assays showed that
IE1 activated the wild-type A20 promoter by 32-fold
but upregulated the NF-κB mutant version by only
6-fold, whereas IE2 did not significantly affect IE1
activity (Figure 2C). These results indicate that IE1
activates the A20 promoter through the NF-κB sites in
reporter assays.
The effect of IE1 expression on A20 expression was
further investigated using IE1-expressing HF cells, which
were produced by retroviral vector transduction. We
found that the A20 level was higher in IE1-expressing
cells than in control cells in both immunoblot assays
(Figure 2D) and IFA (Figure 2E). The A20 unpregulated
by IE1 transfection appeared to accumulate largely in
the cytoplasm. A similar localization pattern of A20 was
observed in IE1-expressing cells after TNFα treatment
(data not shown). Together with the results of reporterassays, these results indicate that IE1 is at least partly
involved in A20 induction.Biphasic regulation of A20 expression by HCMV at a high
viral load
We next investigated the effect of HCMV infection on
A20 expression under high viral load conditions. When
HF cells were infected with HCMV at an MOI of 5, the
A20 protein level was initially increased until 6 to 12 h
after infection, but it was subsequently decreased to
below the basal level of mock-infected cells (Figure 3A).
UV-HCMV also showed a similar pattern of initial increase
and subsequent decrease in A20 protein levels, but the
increase was more profound and sustained than in HCMV,
leading to maximal expression at 24 or 48 h after infection
(Figure 3A). The progression of HCMV infection was
shown by accumulation of viral IE proteins, particularly by
high-level expression of IE2 and its SUMO-modified form
during the late phases of infection (48 to 144 h) (Figure 3A).
The efficacy of UV irradiation to inactivate viral gene
Figure 2 IE1-mediated activation of the A20 promoter in reporter assays. (A) Schematic representation of the NF-κB reporter genes used in
reporter assays (see Materials and Methods). The binding sites for Sp1 and NF-κB are indicated. TK indicates the minimal core region of the HSV-1
TK promoter. (B) Via electroporation, HF cells were cotransfected with 0.5 μg of reporter plasmids containing the A20(NF-κB)-luciferase or the
synthetic NF-κB-luciferase reporter gene (pNFκB-Luc) and 0.5 μg of plasmids expressing HA-IE1 or HA-IE2, as indicated. At 48 h, total cell lysates
were prepared, and luciferase assays were performed. The levels of IE1, IE2, and β-actin are shown by immunoblotting with anti-HA and anti-β-
actin Abs. (C) HF cells were cotransfected with an A20-luciferase reporter plasmid containing wild-type or mutant NF-κB sites [pA20(Wt)-Luc or
pA20(mNF-κBs)-Luc] and plasmids expressing HA-IE1 or HA-IE2, and the luciferase assays and immunoblot analysis were performed. (D and E)
Control HF cells (MIN) or cells expressing IE1 (MIN-IE1) were produced by retroviral transduction. Total cell lysates were prepared and immunoblot
analysis were performed with mouse MAbs for A20, IE1 (810R) or β-actin (D). Cells were fixed in methanol and double-alabel IFA was performed
with anti-A20 and anti-IE1 Abs. Rhodamine/Red X-coupled anti-mouse IgG and FITC-conjugated anti-rabbit IgG were used for visualization (E).
Gu et al. Virology Journal 2014, 11:124 Page 4 of 9
http://www.virologyj.com/content/11/1/124expression was also confirmed by the absence of IE protein
accumulation in UV-HCMV-infected cells (Figure 3A).
To assess whether the temporal regulation of A20
protein level during HCMV infection at high MOIs
reflects transcriptional change, cells were infected with
HCMV or UV-HCMV at an MOI of 5, and the A20
mRNA level was measured at different time points by
qRT-PCR analysis. The results showed that the A20
mRNA level was initially increased at the early phase of
infection, but subsequently decreased at the later phase,
and that UV-HCMV more profoundly activated the
A20 transcription than intact virus (Figure 3B). These
results correlate well with the changes in A20 protein
levels, indicating that A20 expression during HCMV
infection is primarily regulated at the transcriptional
level. Furthermore, a comparison of the effects of HCMV
and UV-HCMV infection suggests that, although A20
induction and termination occur during UV-HCMV
infection, the newly synthesized viral gene product(s)may be involved in limiting A20 induction at high MOIs
during HCMV infection.
Evidence for epigenetic regulation of the A20 promoter
during HCMV infection
To further investigate whether A20 transcription is epi-
genetically regulated, we examined changes in histone
modification in the A20 promoter region after infection
with HCMV and UV-HCMV. The results of ChIP assays
performed at 24 and 48 h showed that the level of histone
H4 acetylation, a marker for euchromatin, was slightly
reduced by HCMV compared to mock-infection, whereas
histone H4 acetylation was increased by UV-HCMV
(Figure 3C). In addition, we measured the level of histone
H3 tri-methylation, a marker for heterochromatin, and
both HCMV and UV-HCMV showed increased levels as
the infection progressed, but HCMV showed a more
profound increase than UV-HCMV at 48 h (Figure 3D).
These ChIP assay results indicate that HCMV infection
Figure 3 Comparison of A20 protein and mRNA levels and histone modifications on the A20 promoters between HCMV and UV-HCMV
infection at a high MOI. (A) HF cells were infected with HCMV or UV-HCMV at an MOI of 5 for the indicated times, and the A20 protein levels
were analyzed by immunoblotting. The progression of the infection with HCMV and the lack of IE1 and IE2 expression with UV-HCMV were shown by
detecting the levels of IE1 and IE2. (B) HF cells were infected as in (A) and total RNAs were prepared at the indicated time points. The A20 mRNA levels
were determined by qRT-PCR. The qRT-PCR results are shown as the mean values and standard errors of three independent experiments. The insert
shows the RT-PCR products of A20 and β-actin (a loading control). (C and D) HF cells were infected with HCMV or UV-HCMV at an MOI of 5. Samples
were prepared at the indicated time points, and ChIP assays were performed using Abs specific for acetylated histone H4 (αAc-H4) (C) and
tri-methylated histone H3 (Lys9) [αTriMe-H3 (K9)] (D). The amounts of coprecipitated DNA were determined by PCR. ChIP with non-specific
immunoglobulin G (IgG) was used as a negative control.
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tions than did UV-HCMV at this high MOI, implicating
a role for the viral gene product(s) in these changes.
Taken together, the results of the qRT-PCR assays and
the ChIP assays in virus-infected cells suggest that the
expression of A20 is epigenetically controlled to limit
its upregulation by the viral gene product(s) during
HCMV infection.
Role of A20 regulation in HCMV growth
To access the significance of the fine regulation of A20
expression in HCMV growth, we investigated the effect
of A20 depletion on HCMV growth. HF cells expressing
control shRNA or shRNA specific for A20 were produced
by lentiviral transduction. The result of immunoblotting
showed a substantial reduction of A20 level in knockdown
cells (Figure 4A). We compared the viral growth curves
at low and high MOIs in control and A20-knockdown
cells. The results showed that the virus titers in A20-
knockdown cells were 15-fold less at 7 days at an MOI of
0.5 and 4-fold less at 3 days at an MOI of 3, compared to
those in control cells (Figure 4B).We then examined the progression of infection by
measuring the levels of viral proteins. We found at both
MOIs that, although the level of IE1 was slightly higher
in A20-knowdown cells than in control cells, the levels
of IE2, p52 (an early protein encoded by UL44), and
pp28 (a late protein encoded by UL99), were lower in
A20-knockdown cells (Figure 4C). We also assessed
NF-κB activity by determining the levels of IκBα. The
results showed that at an MOI of 0.5, the IκBα levels
were less efficiently reduced in control cells than in
A20-knockdown cells, indicating that A20 induction
after virus infection results in the lower NF-κB activity
(Figure 4C, left panels). However, at an MOI of 3, the
degradation of IκBα after virus infection was comparable
between control and A20-knockdown cells, suggesting
that under this high MOI condition, the NF-kB activity
may be less effectively affected by A20 (Figure 4C, right
panels). Taken together, these results suggest that the
expression of A20 and its fine regulation during HCMV
infection may be important for the efficient viral growth
by affecting the accumulation of IE2 and subsequent
expression of viral early and late proteins.
Figure 4 Effects of knockdown on HCMV growth. (A) HF cells expressing control shRNA (shC) and shRNA specific for A20 (shA20) were produced
by lentiviral vectors. The levels of A20 and β-actin (as a loading control) were shown by immunoblotting. (B and C) Control (shC) and A20-knockdown
(shA20) HF cells in 12-well plates were infected with HCMV at an MOI of 0.5 or 3. The growth curves shown represent the total numbers of infectious
center-forming units (IFU) (averages of triplicate) produced in cell culture supernatants at the indicated sampling times (B). Total cell lysates were
prepared at indicated sampling times and the levels of viral immediate-early (IE1 and IE2), early (p52), and late (pp28) proteins and cellular IκBα, A20,
and β-actin proteins were shown by immunoblotting (C).
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In this study, we evaluated the impact of HCMV infection
on A20 expression, which plays a key role in regulating
NF-κB signaling. We found that the A20 expression is
increased upon HCMV infection. This is consistent with a
previous report showing that the binding of HCMV glyco-
proteins to cellular receptors induces A20 transcription in
human monocytes [4]. We also found that IE1 activates
the A20 promoter. The direct activation of A20 promoter
by IE1 is not surprising, since IE1 induces NF-κB activityand the A20 promoter contains two NF-κB binding sites.
Thus, IE1 can exert opposite effects on NF-κB activity;
it can increase NF-κB activity by directly activating the
NF-κB subunit production [3,5-7] and also reduces NF-κB
activity by indirectly inducing A20 expression. We found
that A20 was moderately increased by IE1 expression
alone and localized largely in the cytoplasm, whereas it
was increased to a higher level by HCMV infection and
accumulated at the cytoplasm and to a lesser extent the
nucleus. Therefore, it is likely that other viral genes are
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localization. Similar opposite effects on NF-κB activity
have been observed during Kaposi’s sarcoma-associated
herpesvirus (KSHV) infection [18]. The KSHV vFLIP
protein promotes NF-κB activation by directly binding
to NEMO and deregulates it by indirectly inducing A20
expression. A20 induction by vFLIP is thought to inhibit
vFLIP-induced NF-κB activation. Therefore, both HCMV
and KSHV appear to have a bi-directional regulatory
mechanism to control NF-κB activity.
Notably, we found that the A20 regulation during
HCMV is biphasic. The initial A20 upregulation was
observed at the early phases of infection with both low
and high MOIs. This biphasic regulation of A20 was
more apparent with high MOIs, where the A20 expression
was initially upregulated at the early phases of infection
but downregulated during the late phases and these
differences were controlled at the level of transcription.
Importantly, the upregulation of A20 was much higher
and sustained in UV-HCMV infection than in HCMV
infection. Therefore, it appears that the viral gene
products may be involved in limiting A20 upregula-
tion. Intriguingly, we found that the effects of the
newly synthesized viral gene product(s) on A20 regulation
were different with different viral loads; viral gene
expression promoted A20 upregulation with a low MOI,
whereas it contributed to A20 downregulation with a high
MOI. Further studies are necessary to investigate how
A20 expression is differently regulated by different viral
loads on a single cell level.
The exact role of A20 regulation during HCMV infection
is not clear. Given the critical role of A20 in terminating
canonical NF-κB signaling, HCMV may regulate A20
expression for elaborate modulation of the NF-κB activity
during infection in a timely manner. The initial increase
of A20 level after HCMV infection may just reflect the
increase of NF-κB activity upon virus infection and this
negative feedback regulation is to control excessive NF-κB
activity, which may be harmful by provoking a robust
immune response in vivo. This regulation appears to be
necessary for the efficient progress of viral infection,
since A20 depletion reduced viral growth by affecting
the accumulation of IE2 and subsequent viral early and
late proteins. Notably, the effect of A20 depletion on
HCMV growth was more profound at a lower MOI,
suggesting that reducing the NF-κB activity by A20
induction may be more critical for viral replication
under low MOI conditions. Besides acting as a terminator
in canonical NF-κB signaling, A20 also activates the non-
canonical NF-κB pathway through NIK stabilization [17].
Therefore, it is complicated to expect the output NF-κB
activity after A20 induction during HCMV infection.
Further studies on the exact role of A20 during HCMV
infection are warranted.Conclusion
In this study, we show that the A20 expression is bipha-
sically regulated during HCMV infection. The A20 level
was increased during the early phases of HCMV infection,
but this induction was reduced at the late phases.
Although A20 has been shown to be induced during
HCMV entry, we also found that IE1 activates the A20
promoter through the upstream NF-κB sites. We also
suggest that the downregulation of A20 induction at the
late stages of infection may involve epigenetic controls
of A20 transcription and that the newly produced viral
gene product(s) may facilitate this process. Furthermore,
we show that the A20 expression is required for efficient
HCMV growth, highlighting the importance of the fine
regulation of A20 gene expression in the virus replication
cycle. This A20 regulation may affect NF-κB activity
during HCMV infection or be critical in regulating




Human foreskin fibroblast (HF) and 293 T cells were grown
in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% fetal bovine serum in a 5% CO2-
humidified incubator at 37°C. The cell growth medium also
contained 100 units/ml of penicillin and 100 μg/ml of strep-
tomycin. The stock for the Towne virus and the production
of UV-inactivated virus (UV-HCMV) were previously
described [19]. Infectious center assays for the measure-
ment of viral titers were also previously described [19].
Plasmids
pSG5-based expression plasmids for HA-IE1 and HA-IE2
were described previously [20,21]. The A20 cDNA was
cloned into a pENTR vector (Invitrogen). The retroviral
vectors expressing A20 or IE1 were produced by transfer-
ring the A20 or IE1 cDNA from ENTR vectors to the
pMIN-based destination vector using the LR Clonase
(Invitrogen). Dr. Kun-Sang Chang (The University of
Texas M. D. Anderson Cancer Center, Houston, USA)
provided an A20(−95/+9)-luciferase reporter construct
containing the A20 minimum promoter with two NF-κB
sites [22,23]. In addition, Dr. Rivka Dikstein (The Weizmann
Institute of Science, Rehovot, Israel) provided a set of
pA20(−229/+12)-luciferase reporter plasmids containing
wild-type or mutant NF-κB (mNF-κBs) sites. In these
plasmids, the wild-type A20 promoter contained six
Sp1 sites and two NF-κB sites, whereas the mNF-κBs A20
promoter contained mutant NF-κB sites [24]. pNFκB-Luc,
a luciferase reporter plasmid that contains a synthetic
promoter (herpes simplex virus thymidine kinase TATA-
like promoter) with four copies of NF-kB sites from the
MHC class II gene, was purchased from Clontech.
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Lentiviral vector pLKO.1-TRC control expressing a non-
hairpin control RNA (shC) was purchased from Addgene.
Lentiviral vectors (on a pLKO.1 background) expressing
shRNAs against A20 (shA20) (TRCN50959, 50961, and
218517) were purchased from Open Biosystems. Lentiviral
stocks were prepared by cotransfecting 293 T cells with
the lentiviral vectors together with packaging plasmids
pCMV-DR8.91 expressing the gag-pol, tat, and rev proteins
of human immunodeficiency virus (HIV) and pMD-G
expressing the envelope G protein of vesicular stomatitis
virus (VSV) [25]. For retroviral stocks, 293 T cells were
cotransfected with the retroviral vectors (MIN, or MIN-
IE1) together with packaging plasmids pHIT60 (Gag-Pol)
and pMD-G (VSV-G) [26] using Omicsfect reagents
(Omicsbio). Viral supernatants were harvested 48 h after
transfection. HF cells were transduced by viral vectors in
the presence of polybrene (7.5 μg per ml), and then were
selected with puromycin (1 μg per ml) for lentiviral
evctors or with G418 (0.5 mg/ml; Calbiochem) for
retroviral vectors. For efficient knockdown A20, three
lentiviral vectors expressing three different shRNAs were
used together to transduce HF cells.
Electroporation
HF cells were transfected via electroporation using the
Neon Transfection System (Invitrogen). For each reaction,
3 × 105 cells were suspended in 100 μl of resuspension (R)
buffer and mixed with expression plasmids (up to 4 μg) in
a 1.5-ml tube. After electroporation at 1,300 V and 40 ms,
the cells were plated in six-well plates or chamber slides.
293 T cells were transfected using Omicsfect reagents
(Omicsbio) according to the manufacturer’s instructions.
Immunoblot analysis and antibodies
The standard procedures for immunoblot analysis were
described previously [21]. The mouse monoclonal anti-
body (MAb) for A20 was purchased from Imgenex.
Mouse MAbs for IE1/IE2, p52 (UL44), and pp28 (UL99),
rat anti-HA MAb (3 F10) conjugated to peroxidase, and
mouse MAb against β-actin were described previously
[21]. Rabbit polyclonal Ab (PAb) raised against purified
His-IE1 were described previously [20,21]. Mouse MAb
for IκBα was purchased from AbFrontier. Secondary Abs
for immunoblot analysis were obtained from Jacson
ImmunoResearch Laboratories, Inc.
Indirect immunofluorescence assay (IFA)
Cells were fixed for 5 min in 1% paraformaldehyde
and permeabilized in cold 0.2% Triton X-100, or fixed
for 5 min in cold and rehydrated in cold PBS and then
incubated with appropriate Abs in PBS for 1 h at 37°C
and then incubated with fluorescein isothiocyanate
(FITC)-labeled or rhodamine/red X-coupled donkeyimmunoglobulin G (IgG) (Jackson ImmunoResearch
Laboratories, Inc.). For double-labeling, two different
Abs were incubated together. The slides were examined
and photographed with a Carl Zeiss Axiophot microscope.
RNA isolation and quantitative real-time
reverse-transcription PCR (RT-PCR)
Total RNA was isolated from 2 × 105 cells using TRIzol
reagent (Invitrogen) and a MaXtract High Density Tube
(Qiagen). cDNAs were synthesized using the random
hexamer primers in the SuperScript III system (Invitrogen).
Quantitative real-time PCR was performed using the SYBR
green PCR core reagents (Applied Biosystems) and ABI
Prism SDS software. The primers used to amplify A20
were 5’-CACACAAGGCACTTGGATCC-3’ (forward) and
5’-TCCCCAGGAGTCCGTGCAGC-3’ (reverse).
Chromatin immunoprecipitation (ChIP) assays
ChIP assays were carried out using a kit (Upstate Bio-
technology, Inc.). HF cells (6 × 106) mock-infected or
infected with HCMV were fixed with 1% formaldehyde for
10 min at 24 h after infection and then lysed with the lysis
buffer provided in the kit. ChIP assays were performed
with 5 μg of anti-acetyl-histone H4 Ab (Millipore), anti-
trimethyl-histone H3 (K9) Ab (Millipore), or control IgG.
One-sixth of the lysates were reserved for quantitation of
the DNA present in different samples prior to immuno-
precipitation. Relative changes in precipitated DNA were
calculated via PCR and agarose gel electrophoresis. The
primer sequences used for amplification of the A20
promoter region were 5’-CAGCCCGACCCAGAGAGT
CAC-3’ (forward) and 5’-CTCCGGGCCCCGCGATCC-3’
(reverse). The PCR program used involved 30 amplifica-
tion cycles described as follows: 95°C for 30 s, 62°C for
30 s, and 72°C for 45 s.
Luciferase reporter assay
Cells were lysed using three freeze-thaw steps in 100 μl of
0.25 M Tris–HCl (pH 7.9) containing 1 mM dithiothreitol.
Subsequent procedures were performed as previously
described [21]. A TD-20/20 luminometer (Turner Designs)
was used for the 10-s assay of the photons produced.
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